Research
AI Revolutionizes Biologic Drug Discovery
MIT Technology Review AIhigh confidence
Why it matters
- →AI reduces drug discovery timelines and costs, making new treatments more accessible.
- →It enables targeting of previously untreatable diseases, expanding therapeutic possibilities.
- →Integration with robotics and automation enhances efficiency and scale in drug development.
AI is playing a crucial role in revolutionizing biologic drug discovery, as highlighted by AstraZeneca's efforts to integrate AI into their R&D processes. By using AI to prioritize and design drug candidates, AstraZeneca is able to focus on the most promising molecules, reducing development timelines and costs. The company's 'lab of the future' in Cambridge, Massachusetts, combines AI with robotic automation to create a continuous discovery system. This approach not only speeds up the development process but also enables the exploration of new drug classes and targets previously considered untreatable.
Read originalMore from MIT Technology Review AI
More in Research
Researchresearch
ETH Zurich students create first Swiss humanoid robot
ETH Zurich students have engineered what they claim to be the first Swiss humanoid robot, marking a notable achievement in the country's robotics sector. This project exemplifies the innovative spirit and technical expertise of Swiss engineering students. The team is now actively seeking funding to further develop and potentially commercialize their humanoid creation. This endeavor not only showcases the students' capabilities but also positions Switzerland as an emerging contender in the global robotics arena.
Sifted
© MIT News AIResearchresearch
MIT Develops AI Method for Safety-Critical Tasks
MIT researchers have introduced a novel technique that enhances generative AI models' ability to meet strict safety and task-specific requirements without compromising output quality. By allowing models more freedom during the generation process and enforcing constraints only on the final output, this method, called HardFlow, improves solution quality in high-stakes applications like robotics and computer vision. This approach is particularly significant as it can be applied to existing pretrained models without the need for retraining, making it a versatile tool for safety-critical environments. The development marks a step forward in ensuring AI can be safely and effectively deployed in real-world scenarios where precision is paramount.
